Cleave Biosciences

Burlingame, United States · Founded 2011 · $89.0M raised

Employees
11–50
Founded
2011
Business Model
B2B
Total Funding
$89.0M
Last Round
$37.0M Series BAug 2016
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 8 investors for this company. The full record is or through the API.

About

Cleave Biosciences (later renamed Cleave Therapeutics) is a biopharmaceutical company headquartered in Burlingame, California, focused on developing small molecule therapies targeting protein homeostasis and cellular stress pathways in cancer. The company's lead program centers on VCP/p97 inhibition as a novel mechanism for treating difficult-to-treat cancers.

Summary

Cleave Biosciences is a Biotech company based in Burlingame, United States, founded in 2011. It has raised $89.0M in total across 3 rounds, most recently a $37.0M Series B round in Aug 2016. Investors include US Venture Partners, 5AM Ventures and Clarus Ventures.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BAug 2016
$37.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Avenzo

Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...

San Diego, United States1–10Biotech, Oncology
Series BTotal funding$832.0MSep 2025
Bicycle TherapeuticsIPO

Novel bicyclic peptides and drug conjugates for cancer

Cambridge, United States201–500Biotech, Oncology
Private EquityTotal funding$607.0MJan 2024
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cleave Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/cleave-biosciences"><img src="https://indexed.vc/api/badge/company/cleave-biosciences" alt="Cleave Biosciences on Indexed.vc" width="260" height="76" /></a>